Mirum Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
Mirum Pharmaceuticals, Inc. (MIRM) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 31.30 million shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-05.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-05-05
- Mirum Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 31.30M shares, a 3.96% increase year-over-year.
- Mirum Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 30.54M shares, a 16.94% increase year-over-year.
- Mirum Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 30.37M shares, a 20.83% increase year-over-year.
- Mirum Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 30.27M shares, a 20.83% increase year-over-year.
- Mirum Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 30.32M shares, a 20.08% increase from fiscal 2020.
- Mirum Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 25.25M shares, a 119.84% increase from fiscal 2019.
- Mirum Pharmaceuticals, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 11.49M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 5 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 8 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|---|---|
| 2022-03-31 | 31.30M shares 10-Q · filed 2022-05-05 | 30.92M shares derived: average of 2 quarters · filed 2022-05-05 | 30.73M shares derived: average of 3 quarters · filed 2022-05-05 | 30.62M shares derived: average of 4 quarters · filed 2022-05-05 | ||
| 2021-12-31 | 30.54M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | 30.45M shares derived: average of 2 quarters · filed 2022-03-09 | 30.39M shares derived: average of 3 quarters · filed 2022-03-09 | 30.32M shares 10-K · filed 2022-03-09 | ||
| 2021-09-30 | 30.37M shares 10-Q · filed 2021-11-15 | 30.32M shares derived: average of 2 quarters · filed 2021-11-15 | 30.25M shares 10-Q · filed 2021-11-15 | 29.21M shares derived: average of 4 quarters · filed 2022-05-05 | ||
| 2021-06-30 | 30.27M shares 10-Q · filed 2021-08-05 | 30.19M shares 10-Q · filed 2021-08-05 | 28.83M shares derived: average of 3 quarters · filed 2022-05-05 | 27.91M shares derived: average of 4 quarters · filed 2022-05-05 | ||
| 2021-03-31 | 30.11M shares 10-Q · filed 2022-05-05 | 28.11M shares derived: average of 2 quarters · filed 2022-05-05 | 27.12M shares derived: average of 3 quarters · filed 2022-05-05 | 26.60M shares derived: average of 4 quarters · filed 2022-05-05 | ||
| 2020-12-31 | 26.11M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | 25.62M shares derived: average of 2 quarters · filed 2022-03-09 | 25.43M shares derived: average of 3 quarters · filed 2022-03-09 | 25.25M shares 10-K · filed 2022-03-09 | ||
| 2020-09-30 | 25.13M shares 10-Q · filed 2021-11-15 | 25.09M shares derived: average of 2 quarters · filed 2021-11-15 | 24.97M shares 10-Q · filed 2021-11-15 | 24.40M shares derived: average of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | 25.06M shares 10-Q · filed 2021-08-05 | 24.88M shares 10-Q · filed 2021-08-05 | 24.16M shares derived: average of 3 quarters · filed 2021-08-05 | 22.62M shares derived: average of 4 quarters · filed 2021-08-05 | ||
| 2020-03-31 | 24.70M shares 10-Q · filed 2021-05-06 | 23.71M shares derived: average of 2 quarters · filed 2021-05-06 | 21.80M shares derived: average of 3 quarters · filed 2021-05-06 | 16.99M shares derived: average of 4 quarters · filed 2021-05-06 | ||
| 2019-12-31 | 22.71M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | 20.35M shares derived: average of 2 quarters · filed 2021-03-09 | 14.42M shares derived: average of 3 quarters · filed 2021-03-09 | 11.49M shares 10-K · filed 2021-03-09 | ||
| 2019-09-30 | 18.00M shares 10-Q · filed 2020-11-12 | 10.27M shares derived: average of 2 quarters · filed 2020-11-12 | 7.75M shares 10-Q · filed 2020-11-12 | |||
| 2019-06-30 | 2.55M shares 10-Q · filed 2020-08-06 | 2.53M shares 10-Q · filed 2020-08-06 | ||||
| 2019-03-31 | 2.52M shares 10-Q · filed 2020-05-07 | |||||
| 2018-12-31 | 899.33K shares 10-K · filed 2020-03-12 | |||||
| 2018-09-30 | 476.90K shares 10-Q · filed 2019-11-06 | 290.57K shares 10-Q · filed 2019-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |